ROIV
Roivant Sciences Ltd. Earnings
$22.5
Earnings Summary
Revenue | $1.57Mn |
Net Profits | $-113.52Mn |
Net Profit Margins | -7225.91% |
Roivant Sciences Ltd.’s revenue fell -64.89% since last year same period to $1.57Mn in the Q3 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated -27.6% fall in its revenue since last 3-months.
Roivant Sciences Ltd.’s net profit jumped 50.68% since last year same period to $-113.52Mn in the Q3 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated 49.18% jump in its net profits since last 3-months.
Roivant Sciences Ltd.’s net profit margin fell -40.48% since last year same period to -7225.91% in the Q3 2025. On a quarterly growth basis, Roivant Sciences Ltd. has generated 29.8% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.32 |
EPS Estimate Current Year | -0.32 |
Roivant Sciences Ltd.’s earning per share (EPS) estimates for the current quarter stand at -0.32 - a -1.38% fall from last quarter’s estimates.
Roivant Sciences Ltd.’s earning per share (EPS) estimates for the current year stand at -0.32.
Key Ratios
Earning Per Share (EPS) | 0 |
Roivant Sciences Ltd.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2025. This indicates that the Roivant Sciences Ltd. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-11-10 | -0.32 | -0.17 | 46.88% |
2026-02-16 | -0.32 | 0 | 100% |
2025-08-11 | -0.25 | -0.25 | -1.58% |
2025-05-29 | -0.26 | -0.29 | -10.31% |